Author(s):
Dipak P. Kardile, Pravin B. Awate, Vishwas C. Bhagat, Adinath C. Bhusari, Nilesh A. Narote, Rajkumar V. Shete
Email(s):
kardiledeepak@gmail.com
DOI:
10.52711/0974-360X.2024.00579
Address:
Dipak P. Kardile*, Pravin B. Awate, Vishwas C. Bhagat, Adinath C. Bhusari, Nilesh A. Narote, Rajkumar V. Shete
Department of Pharmaceutics, Rajgad Dnyanpeeth’s College of Pharmacy, Bhor Tal. Bhor Dist. Pune 412206.
*Corresponding Author
Published In:
Volume - 17,
Issue - 8,
Year - 2024
ABSTRACT:
The present research work aim was to formulate a fast-dissolving sublingual film containing Aripiprazole, which is used in the treatment of schizophrenia and bipolar disorder. Fast Dissolving Sublingual Film Containing Aripiprazole prepared by using the solvent casting method. Aripiprazole is a BCS IV drug with poor solubility and poor permeability causing poor systemic absorption. Fast dissolving sublingual film prepared by using Design-Expert® version13 software with 32 full factorial designs in which Film-forming polymer HPMC K4M and plasticizers like PEG 400, and PVA are used in different concentrations. The formulated batches was evaluated for mechanical properties, surface pH, folding endurance, drug content, swelling property, SEM analysis, and in vitro % drug release. The characterization of the film shows satisfactory results following mechanical properties of a film like weight variation and thickness. The formulation (F4, F12) containing the highest concentration of plasticizer shows a high folding endurance ranges from 90-100%. FTIR and DCS studies reveal that there are no interactions means drugs and excipients are compatible with each other. Formulation F4 is optimized batch passes evaluation parameters and maximum % drug release i.e. 98.79 % ±0.36 within 1.5 min. Therefore, the sublingual film is an effective approach for BCS IV and III class drugs by avoiding first-pass metabolism with rapid onset of action and better patient compliance in psychotic disorders.
Cite this article:
Dipak P. Kardile, Pravin B. Awate, Vishwas C. Bhagat, Adinath C. Bhusari, Nilesh A. Narote, Rajkumar V. Shete. Design, In-Vitro Characterization and Optimization of Fast Dissolving Sublingual Film containing Aripiprazole. Research Journal of Pharmacy and Technology. 2024; 17(8):3725-9. doi: 10.52711/0974-360X.2024.00579
Cite(Electronic):
Dipak P. Kardile, Pravin B. Awate, Vishwas C. Bhagat, Adinath C. Bhusari, Nilesh A. Narote, Rajkumar V. Shete. Design, In-Vitro Characterization and Optimization of Fast Dissolving Sublingual Film containing Aripiprazole. Research Journal of Pharmacy and Technology. 2024; 17(8):3725-9. doi: 10.52711/0974-360X.2024.00579 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2024-17-8-27
REFERENCES:
1. Vaishali D. Sangale. Smita S. Aher. Ravindra B. Saudagar. Fast Dissolving Sublingual Film. Asian J. Res. Pharm. Sci. 2016; 153–160.
2. Chonkar A. D. Bhagawati S. T. Udupa N. An Overview on Fast Dissolving Oral Films. Asian J. Pharm. Technol. 2015; 5(129)
3. Hemlata Sahu. Amit Alexander.et al. Formulation and Evaluation of Risperidone Loaded Mouth-Dissolving Film. Res. J. Pharm. Technol. 2018; 11(7): 2922-2925.
4. Hussein O. Ammar. Mahmoud M. Ghorab. Amira M. Ghoneim. Marwa S. Saleh. Schizophrenia: Stages, Approaches in Treatment and Future Prospects. Research J. Pharm. and Tech. 2019; 12(8): 3960-3966.doi: 10.5958/0974-360X.2019.00682.6.
5. Chettupalli A.K. Padmanabha Rao A. Kuchukuntla M. Bakshi V. Development and Optimization of Aripiprazole ODT by using box-Behnken Design. Research J. Pharm. and Tech. 2020; 13(12): 6195-6201. doi: 10.5958/0974-360X.2020.01080.
6. Umar Faruk Sha A. Pravin S. Formulation and Evaluation of Mouth Dissolving Films of Amlodipine Besylate by using Natural and Synthetic Polymers. Research Journal of Pharmacy and Technology. 2022; 15(11): 5154-7. doi: 10.52711/0974-360X.2022.00867.
7. Dasari Nirmala. Swapna Nandhini. M. Sudhakar. Design and evaluation of fast dissolving oral films of Zolpidem by solvent casting method. Asian J. Pharm. Res. 2016; 6(2): 67-71. doi: 10.5958/2231-5691.2016.00012.5.
8. Sara Sadique, Ramya Sri S. Preparation and Evaluation of Fast Dissolving Oral Film of Losartan Potassium. Res. J. Pharma. Dosage Forms and Tech. 2020; 12(1): 13-16. doi: 10.5958/0975-4377.2020.00003.8
9. Patel A.A. Shaikh S.N. Patel H. Band A. Shaoor A. Designing fabrication and evaluation of Oral fast Disintegrating tablet of Ranitidine HCL. Journal of Drug Delivery and Therapeutics. 2019; 9(1): 95-102. doi:10.22270/jddt.v9i1.2176.
10. Smita S. Aher, Vaishali D. Sangale, Ravindra B. Saudagr. Formulation and evaluation of sublingual film of Hydralazine Hydrochloride. Research J. Pharm. and Tech. 2016; 9(10): 1681-1690.
11. Latif R. Ashfaq M. Formulation Development and Evaluation of Fast Dissolving Oral Films of Alprazolam. Journal of Advances in Medical and Pharmaceutical Sciences. 2019; 21(4): 1–20. doi:10.9734/jamps/2019/v21i430142.
12. Kamma Keerthi Sai. Formulation Development and In vitro Evaluation of Memantine Hydrochloride Fast Dissolving Oral Films employing different grades of Hydroxy Propyl Methyl Cellulose. Research Journal of Pharmacy and Technology. 2022; 15(1): 17-3. doi: 10.52711/0974-360X.2022.00004.
13. Rathore N. Nizami T. Mangal A. Malviya N. Chauhan V. and Salvi N. Formulation and Evaluation of Fast Dissolving Oral Films of an Anti-Migrain Drug (Zolmitriptan). Journal of Drug Delivery and Therapeutics. 2019; 9(2-A): 59-61.
14. Muhammed. Rozhan A. Omer. Huner K.Formulation and Evaluation of Fast Dissolving Oral Film of Imipramine. Polytechnic Journal. 2020; 10(1): 30. doi:10.25156/ptj.v10n1y2020.pp182-188.
15. A.Srinivas. N. Bhikshapathi. Fast Dissolving Oral Films of Pramipexole HCl monohydrate: Preparation and in vitro evaluation. Research J. Pharm. and Tech. 2018; 11(3): 1001-1008. doi: 10.5958/0974-360X.2018.00187.7.
16. Salama. Alaa. Basha. Mona. Salama. Abeer. Micellar buccal film for safe and effective control of seizures: Preparation, in vitro characterization, ex-vivo permeation studies and in vivo assessment. Eur. J. Pharm. Sci. 2021; 166(1): 105978. doi:10.1016/j.ejps.2021.105978.